Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

8.430 -0.020 (-0.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 620,898
Open 8.700
Bid (Size) 6.850 (1)
Ask (Size) 7.000 (2)
Prev. Close 8.450
Today's Range 8.400 - 8.825
52wk Range 4.180 - 39.45
Shares Outstanding 29,940,637
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
  
Via Benzinga
DermTech: Q2 Earnings Insights
  DermTech (NASDAQ:DMTK) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga

Performance

YTD
-51.97%
-51.97%
1 Month
+44.10%
+44.10%
3 Month
+25.07%
+25.07%
6 Month
-36.52%
-36.52%
1 Year
-77.91%
-77.91%

More News

Read More
DermTech Reports Second-Quarter 2022 Financial Results; Company Updates Full-Year 2022 Outlook
From DermTech, Inc.
Via Business Wire
Earnings Preview For DermTech
Via Benzinga
DermTech Appoints Chief Compliance Officer and SVP of Research and Development
From DermTech, Inc.
Via Business Wire
DermTech Announces Release Date for Second-Quarter 2022 Financial Results
From DermTech, Inc.
Via Business Wire
Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
IBM And 20 Stocks Moving Premarket
Via Benzinga
DermTech Appoints Two New Board Members
From DermTech, Inc.
Via Business Wire
DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases
From DermTech, Inc.
Via Business Wire
DermTech to Present on Genomic Innovation in Dermatology at AHIP 2022
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech to Present at the William Blair Growth Stock Conference
From DermTech, Inc.
Via Business Wire
DermTech Sponsors The Sun Bus to Bring Free Skin Cancer Screenings to More Than 50 Locations Across the U.S.
From DermTech, Inc.
Via Business Wire
DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting
From DermTech, Inc.
Via Business Wire
Looking Into DermTech's Return On Capital Employed
Via Benzinga
DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program
From DermTech, Inc.
Via Business Wire
DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams
From DermTech
Via Business Wire
DermTech: Q1 Earnings Insights
Via Benzinga
DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook
From DermTech, Inc.
Via Business Wire
DermTech's Earnings Outlook
Via Benzinga
DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
From DermTech, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.